NCT02819024View on ClinicalTrials.gov

Dexamethasone Effects in Patients With Refractory Non-Small Cell Lung Cancer Using FLT Positron Emission Tomography

NACompletedINTERVENTIONAL
Enrollment

6

Participants

Timeline

Start Date

June 30, 2016

Primary Completion Date

October 17, 2019

Study Completion Date

October 17, 2019

Conditions
Recurrent Non-Small Cell Lung CarcinomaStage IIIA Non-Small Cell Lung CancerStage IIIB Non-Small Cell Lung CancerStage IV Non-Small Cell Lung Cancer
Interventions
DRUG

Dexamethasone

Given PO BID

DEVICE

Device for PET

Undergo 18F-FLT PET scan

OTHER

Laboratory Biomarker Analysis

Correlative studies

PROCEDURE

Positron Emission Tomography

Undergo 18F-FLT PET scan

Trial Locations (1)

48201

Wayne State University/Karmanos Cancer Institute, Detroit

All Listed Sponsors
collaborator

National Cancer Institute (NCI)

NIH

lead

Barbara Ann Karmanos Cancer Institute

OTHER

NCT02819024 - Dexamethasone Effects in Patients With Refractory Non-Small Cell Lung Cancer Using FLT Positron Emission Tomography | Biotech Hunter | Biotech Hunter